Progyny (PGNY) Competitors $22.60 -0.13 (-0.55%) As of 11:01 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PGNY vs. GH, OPCH, RDNT, BTSG, SHC, VCYT, SGRY, LFST, CON, and PRVAShould you be buying Progyny stock or one of its competitors? The main competitors of Progyny include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. Progyny vs. Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Veracyte Surgery Partners LifeStance Health Group Concentra Group Holdings Parent Privia Health Group Guardant Health (NASDAQ:GH) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, community ranking, institutional ownership and dividends. Is GH or PGNY more profitable? Progyny has a net margin of 5.03% compared to Guardant Health's net margin of -74.02%. Progyny's return on equity of 11.36% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-74.02% -1,200.44% -29.88% Progyny 5.03%11.36%7.87% Does the media favor GH or PGNY? In the previous week, Guardant Health had 2 more articles in the media than Progyny. MarketBeat recorded 7 mentions for Guardant Health and 5 mentions for Progyny. Progyny's average media sentiment score of 1.06 beat Guardant Health's score of 0.76 indicating that Progyny is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Progyny 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer GH or PGNY? Guardant Health currently has a consensus price target of $42.63, indicating a potential downside of 10.56%. Progyny has a consensus price target of $25.50, indicating a potential upside of 12.86%. Given Progyny's higher possible upside, analysts clearly believe Progyny is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00Progyny 0 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.31 Which has stronger earnings and valuation, GH or PGNY? Progyny has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$563.95M10.44-$479.45M-$4.24-11.24Progyny$1.09B1.77$62.04M$0.5838.96 Does the MarketBeat Community believe in GH or PGNY? Guardant Health received 184 more outperform votes than Progyny when rated by MarketBeat users. However, 70.92% of users gave Progyny an outperform vote while only 70.30% of users gave Guardant Health an outperform vote. CompanyUnderperformOutperformGuardant HealthOutperform Votes28470.30% Underperform Votes12029.70% ProgynyOutperform Votes10070.92% Underperform Votes4129.08% Do institutionals and insiders believe in GH or PGNY? 92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 94.9% of Progyny shares are owned by institutional investors. 5.5% of Guardant Health shares are owned by company insiders. Comparatively, 12.3% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, GH or PGNY? Guardant Health has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500. SummaryProgyny beats Guardant Health on 13 of the 18 factors compared between the two stocks. Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PGNY vs. The Competition Export to ExcelMetricProgynyhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.92B$2.30B$5.78B$9.09BDividend YieldN/A7.31%5.28%4.00%P/E Ratio38.9617.6787.6618.39Price / Sales1.778.881,022.5877.90Price / Cash34.5210.5137.4433.55Price / Book3.923.225.164.81Net Income$62.04M$72.19M$108.96M$223.02M7 Day Performance-4.01%-3.15%2.82%1.50%1 Month Performance29.63%7.82%2.54%-0.57%1 Year Performance-43.37%-14.22%26.30%24.02% Progyny Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PGNYProgyny3.8337 of 5 stars$22.60-0.6%$25.50+12.9%-41.5%$1.92B$1.09B38.96310Positive NewsGHGuardant Health3.8839 of 5 stars$47.07+0.2%$42.63-9.4%+123.6%$5.85B$692.26M-11.171,779OPCHOption Care Health4.5488 of 5 stars$30.82-0.3%$32.25+4.6%+0.3%$5.24B$4.30B25.887,802Positive NewsRDNTRadNet3.7342 of 5 stars$66.56+1.7%$75.50+13.4%+81.3%$4.93B$1.62B-951.2210,288News CoverageBTSGBrightSpring Health Services2.96 of 5 stars$23.65+0.2%$19.42-17.9%+110.8%$4.12B$8.83B-91.0035,000SHCSotera Health3.6555 of 5 stars$13.68-0.3%$16.08+17.6%-8.6%$3.87B$1.05B54.703,000Positive NewsVCYTVeracyte4.0266 of 5 stars$45.23-0.5%$42.00-7.1%+84.3%$3.51B$361.05M-302.12790News CoverageGap DownSGRYSurgery Partners2.9218 of 5 stars$25.42-0.3%$36.56+43.8%-19.5%$3.23B$2.74B-52.9213,500LFSTLifeStance Health Group1.0102 of 5 stars$8.08+1.4%$8.70+7.7%+43.0%$3.09B$1.06B-31.029,325Positive NewsCONConcentra Group Holdings ParentN/A$23.29-0.1%$28.63+22.9%N/A$2.96B$1.84B0.0011,000Positive NewsPRVAPrivia Health Group2.7152 of 5 stars$22.85+0.0%$24.88+8.9%+21.1%$2.74B$1.66B228.281,102 Related Companies and Tools Related Companies Guardant Health Alternatives Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Veracyte Alternatives Surgery Partners Alternatives LifeStance Health Group Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PGNY) was last updated on 2/6/2025 by MarketBeat.com Staff From Our PartnersNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s ‘Agents’ StrikeHe might be the richest man on the planet – but Elon Musk just landed himself a new job... In a move that c...Altimetry | SponsoredElon Musk: The U.S. Dollar is Doomed Unless We ActBillionaire Warren Buffett told CNBC the U.S. dollar is on the path to disaster. And Charles Schwab reports, "...Stansberry Research | SponsoredAmazon coin set to soar 25X – starting January 20thThis tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.